Industrial & Infrastructure Capex Trends Across Real Estate, Pharma, and Chemicals

Gemini said The following 85-word summary and key questions are based on the provided analysis of the biotech clinical trials ecosystem. Summary (Exactly 85 Words) The biotech clinical trial market is projected to reach $150 billion by 2030, growing at a 6–8% CAGR. Post-COVID momentum in mRNA and oncology drives this expansion, alongside rising Global Capability Centers in the APAC region. Small-to-mid-sized biotechs contribute significantly to CRO revenues, though the transition from Phase II to III remains a primary bottleneck. Elite performance is defined by rapid site activation and unified digital platforms like Medidata and Veeva, which outperform fragmented legacy systems by streamlining complex data across their clinical trial lifecycle.